TD Cowen on Abbott Labs (ABT): 'We Expect A Good Q4 Report'

January 20, 2026 9:16 AM EST Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $145.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login